Skip to main content

Table 2 Primary outcome measures

From: Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study

Change in rate pressure product at 0.1 mV ST-segment depression during sequential exercise tolerance testing performed over a 6-week study period
Change in degree of ST-segment depression at peak exercise during sequential exercise tolerance testing performed over a 6-week study period